Cargando…
Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors
Molecular imaging of brain tumors remains a great challenge, despite the advances made in imaging technology. An anti-inflammatory compound may be a useful tool for this purpose because there is evidence of inflammatory processes in brain tumor micro-environments. Fluorooctylfenbufen amide (FOFA) wa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273898/ https://www.ncbi.nlm.nih.gov/pubmed/27007363 http://dx.doi.org/10.3390/molecules21030387 |
_version_ | 1783377493559869440 |
---|---|
author | Huang, Ying-Cheng Chang, Yu-Chia Yeh, Chun-Nan Yu, Chung-Shan |
author_facet | Huang, Ying-Cheng Chang, Yu-Chia Yeh, Chun-Nan Yu, Chung-Shan |
author_sort | Huang, Ying-Cheng |
collection | PubMed |
description | Molecular imaging of brain tumors remains a great challenge, despite the advances made in imaging technology. An anti-inflammatory compound may be a useful tool for this purpose because there is evidence of inflammatory processes in brain tumor micro-environments. Fluorooctylfenbufen amide (FOFA) was prepared from 8-chlorooctanol via treatment with potassium phthalimide, tosylation with Ts(2)O, fluorination with KF under phase transfer catalyzed conditions, deprotection using aqueous hydrazine, and coupling with fenbufen. The corresponding radiofluoro product [(18)F]FOFA, had a final radiochemical yield of 2.81 mCi and was prepared from activated [(18)F]F(−) (212 mCi) via HPLC purification and concentration. The radiochemical purity was determined to be 99%, and the specific activity was shown to exceed 22 GBq/μmol (EOS) based on decay-corrected calculations. Ex-vivo analysis of [(18)F]FOFA in plasma using HPLC showed that the agent had a half-life of 15 min. PET scanning showed significant accumulation of [(18)F]FOFA over tumor loci with reasonable contrast in C6-glioma bearing rats. These results suggest that this molecule is a promising agent for the visualization of brain tumors. Further investigations should focus on tumor micro-environments. |
format | Online Article Text |
id | pubmed-6273898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62738982018-12-28 Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors Huang, Ying-Cheng Chang, Yu-Chia Yeh, Chun-Nan Yu, Chung-Shan Molecules Article Molecular imaging of brain tumors remains a great challenge, despite the advances made in imaging technology. An anti-inflammatory compound may be a useful tool for this purpose because there is evidence of inflammatory processes in brain tumor micro-environments. Fluorooctylfenbufen amide (FOFA) was prepared from 8-chlorooctanol via treatment with potassium phthalimide, tosylation with Ts(2)O, fluorination with KF under phase transfer catalyzed conditions, deprotection using aqueous hydrazine, and coupling with fenbufen. The corresponding radiofluoro product [(18)F]FOFA, had a final radiochemical yield of 2.81 mCi and was prepared from activated [(18)F]F(−) (212 mCi) via HPLC purification and concentration. The radiochemical purity was determined to be 99%, and the specific activity was shown to exceed 22 GBq/μmol (EOS) based on decay-corrected calculations. Ex-vivo analysis of [(18)F]FOFA in plasma using HPLC showed that the agent had a half-life of 15 min. PET scanning showed significant accumulation of [(18)F]FOFA over tumor loci with reasonable contrast in C6-glioma bearing rats. These results suggest that this molecule is a promising agent for the visualization of brain tumors. Further investigations should focus on tumor micro-environments. MDPI 2016-03-21 /pmc/articles/PMC6273898/ /pubmed/27007363 http://dx.doi.org/10.3390/molecules21030387 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huang, Ying-Cheng Chang, Yu-Chia Yeh, Chun-Nan Yu, Chung-Shan Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title_full | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title_fullStr | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title_full_unstemmed | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title_short | Synthesis and Biological Evaluation of an (18)Fluorine-Labeled COX Inhibitor—[(18)F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors |
title_sort | synthesis and biological evaluation of an (18)fluorine-labeled cox inhibitor—[(18)f]fluorooctyl fenbufen amide—for imaging of brain tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273898/ https://www.ncbi.nlm.nih.gov/pubmed/27007363 http://dx.doi.org/10.3390/molecules21030387 |
work_keys_str_mv | AT huangyingcheng synthesisandbiologicalevaluationofan18fluorinelabeledcoxinhibitor18ffluorooctylfenbufenamideforimagingofbraintumors AT changyuchia synthesisandbiologicalevaluationofan18fluorinelabeledcoxinhibitor18ffluorooctylfenbufenamideforimagingofbraintumors AT yehchunnan synthesisandbiologicalevaluationofan18fluorinelabeledcoxinhibitor18ffluorooctylfenbufenamideforimagingofbraintumors AT yuchungshan synthesisandbiologicalevaluationofan18fluorinelabeledcoxinhibitor18ffluorooctylfenbufenamideforimagingofbraintumors |